Kim Tieu

Author PubWeight™ 45.18‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci U S A 2009 8.25
2 Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 2002 4.38
3 Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture. Nat Neurosci 2010 3.38
4 NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Proc Natl Acad Sci U S A 2003 2.91
5 Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. Proc Natl Acad Sci U S A 2003 2.74
6 Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem 2009 2.70
7 Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP. Proc Natl Acad Sci U S A 2002 2.64
8 Neuronal adenosine release, and not astrocytic ATP release, mediates feedback inhibition of excitatory activity. Proc Natl Acad Sci U S A 2012 1.74
9 MPTP as a mitochondrial neurotoxic model of Parkinson's disease. J Bioenerg Biomembr 2004 1.69
10 Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage. Proc Natl Acad Sci U S A 2005 1.68
11 Perturbations in mitochondrial dynamics induced by human mutant PINK1 can be rescued by the mitochondrial division inhibitor mdivi-1. J Biol Chem 2010 1.65
12 The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway. Proc Natl Acad Sci U S A 2009 1.43
13 Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice. J Neurosci 2005 1.40
14 Pathogenic role of glial cells in Parkinson's disease. Mov Disord 2003 1.25
15 Silencing of the Pink1 gene expression by conditional RNAi does not induce dopaminergic neuron death in mice. Int J Biol Sci 2007 1.20
16 Astrocytes and therapeutics for Parkinson's disease. Neurotherapeutics 2010 1.18
17 Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3. Proc Natl Acad Sci U S A 2011 1.03
18 Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin. PLoS One 2013 0.92
19 D-β-hydroxybutyrate is protective in mouse models of Huntington's disease. PLoS One 2011 0.92
20 Glial cell response: A pathogenic factor in Parkinson's disease. J Neurovirol 2002 0.83
21 Cultured astrocytes do not release adenosine during hypoxic conditions. J Cereb Blood Flow Metab 2011 0.82
22 Free radical and nitric oxide toxicity in Parkinson's disease. Adv Neurol 2003 0.81
23 Neurosteroid transport by the organic solute transporter OSTα-OSTβ. J Neurochem 2010 0.80